Log on / register
Feedback | Support | My details
Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease.
Gu X, André VM, Cepeda C, Li SH, Li XJ, Levine MS, Yang XW
Mol Neurodegener 2007, 2:8
[Full text] [PubMed] [Related articles]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Neocortical expression of mutant huntingtin is not required for alterations in striatal gene expression or motor dysfunction in a transgenic mouse.
Brown TB, Bogush AI, Ehrlich ME
Hum Mol Genet 2008 Oct 15, 17:3095-104
 [PubMed Central] [PubMed] [Related articles]
2.
Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's disease.
Wang CE, Tydlacka S, Orr AL, Yang SH, Graham RK, Hayden MR, Li S, Chan AW, Li XJ
Hum Mol Genet 2008 Sep 1, 17:2738-51
 [PubMed Central] [PubMed] [Related articles]
3.
Neuroprotective effects of inositol 1,4,5-trisphosphate receptor C-terminal fragment in a Huntington's disease mouse model.
Tang TS, Guo C, Wang H, Chen X, Bezprozvanny I
J Neurosci 2009 Feb 4, 29:1257-66
 [PubMed Central] [PubMed] [Related articles]
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.